| CPC A61K 9/127 (2013.01) [A61K 9/1277 (2013.01); A61K 9/146 (2013.01); A61K 9/5026 (2013.01); A61K 31/404 (2013.01); A61K 31/44 (2013.01); A61K 31/47 (2013.01); A61K 31/53 (2013.01); A61K 47/24 (2013.01); A61P 35/00 (2018.01)] | 18 Claims |

|
1. A method of treating a cancer in a subject, the method comprising administering to a subject in need thereof a pharmaceutical composition of a pharmaceutically effective amount of a chemoembolization agent, comprising:
an embolizing particle or microsphere;
an encapsulating agent, the encapsulating agent being affixed to the embolizing particle or microsphere through ionic or other non-covalent interactions,
one or more therapeutic agents contained within the encapsulating agent,
wherein each therapeutic agent is independently uncharged or weakly charged or has low solubility in aqueous media at physiological pH; and
wherein the encapsulating agent is configured to release the one or more therapeutic agents.
|